Health-care companies fell, but not by as much as the broad market, as traders rotated into sectors less sensitive to interest-rate movements.
Health-care companies fell, but not by as much as the broad market, as traders rotated into sectors less sensitive to interest-rate movements.
BioNTech shares slid after the biotech firm scrapped a clinical trial for its mRNA cancer vaccine, marking the second setback this year.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
August 28, 2026 17:37 ET (21:37 GMT)
Health-care companies fell as traders continued to rotate out of a sector beset by growth and regulatory concerns.
Health-care companies rose as traders rotated back into sectors that are less sensitive to shifts in inflation and oil prices.
Health-care companies fell, but not by much, as traders continued rotating out of tech into lagging sectors.
Health-care companies fell as traders rotated out of defensive sectors and back into the tech sector.
Health-care companies ticked down as traders rotated out of defensive sectors into technology companies.
Health-care companies fell as traders continued to rotate out of the sector.
